CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas

被引:26
|
作者
Kim, Seong Ho [1 ,2 ]
Kim, Se Hyung [1 ,2 ]
Kim, Min-A [3 ]
Shin, Cheong-il [1 ,2 ]
Han, Joon Koo [1 ,2 ]
Choi, Byung Ihn [1 ,2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehangno, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
基金
新加坡国家研究基金会;
关键词
Stomach; Neuroendocrine tumour; Adenocarcinoma; Metastasis; Computed tomography; ENDOCRINE TUMORS; CARCINOID-TUMORS; PATHOGENESIS; METASTASES; DISTENSION; CELL;
D O I
10.1007/s00330-015-3600-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To evaluate the differential CT features of gastric poorly-differentiated neuroendocrine tumours (PD-NETs) from well-differentiated NETs (WD-NETs) and gastric adenocarcinomas (ADCs) and to suggest differential features of hepatic metastases from gastric NETs and ADCs. Our study population was comprised of 36 patients with gastric NETs (18 WD-NETs, 18 PD-NETs) and 38 patients with gastric ADCs who served as our control group. Multiple CT features were assessed to identify significant differential CT findings of PD-NETs from WD-NETs and ADCs. In addition, CT features of hepatic metastases including the metastasis-to-liver ratio were analyzed to differentiate metastatic NETs from ADCs. The presence of metastatic lymph nodes was the sole differentiator of PD-NETs from WD-NETs (P = .001, odds ratio = 56.67), while the presence of intact overlying mucosa with mucosal tenting was the sole significant CT feature differentiating PD-NETs from ADCs (P = .047, odds ratio = 15.3) For hepatic metastases, metastases from NETs were more hyper-attenuated than those from ADCs. The presence of metastatic LNs and intact overlying mucosa with mucosal tenting are useful CT discriminators of PD-NETs from WD-NETs and ADCs, respectively. In addition, a higher metastasis-to-liver ratio may help differentiate hepatic metastases of gastric NETs from those of gastric ADCs with high accuracy. aEuro cent Presence of metastatic LNs is a useful differentiator of PD-NETs from WD-NETs. aEuro cent Intact overlying mucosa with mucosal tenting suggests PD-NETs more than gastric ADCs. aEuro cent Metastatic LNs are larger in size and greater in necrotic volume in PD-NETs. aEuro cent Hepatic metastases from gastric NETs are more hyper-attenuated than those from ADCs.
引用
收藏
页码:1946 / 1957
页数:12
相关论文
共 50 条
  • [31] Gastric Neuroendocrine Tumours
    Crosby, David A.
    Donohoe, Claire L.
    Fitzgerald, Louise
    Muldoon, Cian
    Hayes, Brian
    O'Toole, Dermot
    Reynolds, John V.
    DIGESTIVE SURGERY, 2012, 29 (04) : 331 - 348
  • [32] Sudden onset of multiple seborrhoeic keratoses in a patient with well-differentiated neuroendocrine tumours of the gut
    Schmidt, Veronika
    Blum, Roland
    Moehrenschlager, Matthias
    GUT, 2023, 72 (07)
  • [33] Are grade III well-differentiated neuroendocrine tumours a unique clinic-pathological entity?
    Kalvala, J.
    Wood, M.
    Rao, A. R.
    Arora, A.
    Adhikaree, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1614 - S1614
  • [34] Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours
    Samsom, Kris G.
    Levy, Sonja
    van Veenendaal, Linde M.
    Roepman, Paul
    Kodach, Liudmila L.
    Steeghs, Neeltje
    Valk, Gerlof D.
    Wouter Dercksen, M.
    Kuhlmann, Koert F. D.
    Verbeek, Wieke H. M.
    Meijer, Gerrit A.
    Tesselaar, Margot E. T.
    van den Berg, Jose G.
    HISTOPATHOLOGY, 2021, 78 (04) : 556 - 566
  • [35] Proton Pump Inhibitors-Associated Well-Differentiated Gastric Neuroendocrine Tumors
    Vincent Quoc-Huy Trinh
    Shi, Chanjuan
    Ma, Changqing
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 782 - 784
  • [36] Proton Pump Inhibitors-Associated Well-Differentiated Gastric Neuroendocrine Tumors
    Trinh, Vincent Quoc-Huy
    Shi, Chanjuan
    Ma, Changqing
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 782 - 784
  • [37] Somatostatin receptor 2A expression is not restricted to well differentiated neuroendocrine tumours but also occurs in poorly differentiated neuroendocrine carcinomas of pancreatic and extrapancreatic origin
    Konukiewitz, B.
    Schlitter, A. M.
    Pfister, D.
    Segler, A.
    Agaimy, A.
    Sipos, B.
    Zamboni, G.
    Esposito, I.
    Kloeppel, G.
    VIRCHOWS ARCHIV, 2015, 467 : S4 - S4
  • [38] European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours
    Lamarca, Angela
    Bartsch, Detlef K.
    Caplin, Martyn
    Kos-Kudla, Beata
    Kjaer, Andreas
    Partelli, Stefano
    Rinke, Anja
    Janson, Eva Tiensuu
    Thirlwell, Christina
    van Velthuysen, Marie-Louise F.
    Vullierme, Marie-Pierre
    Pavel, Marianne
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 (09)
  • [39] Coexistent poorly-differentiated neuroendocrine cell carcinoma and non-invasive well-differentiated adenocarcinoma in tubulovillous adenoma of the rectum : report of a case
    Kuratate, Shinji
    Inoue, Seiya
    Chikakiyo, Motoya
    Kaneda, Yuji
    Harino, Yukari
    Hirose, Toshiyuki
    Yagi, Toshiyuki
    Saitoh, Seiya
    Sumitomo, Masayuki
    Fujino, Ryozo
    Satake, Nobuo
    JOURNAL OF MEDICAL INVESTIGATION, 2010, 57 (3-4): : 338 - 344
  • [40] Immunohistochemical evaluation of the phosphorylated AKT1 expression in well-differentiated pancreatic neuroendocrine tumours
    Delektorskaya, V.
    Solovieva, O.
    Chemeris, G.
    Patyutko, Y.
    VIRCHOWS ARCHIV, 2017, 471 : S29 - S29